Emerson Electric Co.
EMR
$111.76
$2.562.34%
Weiss Ratings | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Risk Index | Fair | |||
Risk Grade | C+ | |||
Reward Grade | C+ | |||
Rating Factors | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | Fair | |||
Growth Index | Weak | |||
Efficiency Index | Excellent | |||
Solvency Index | Excellent | |||
Total Return Index | Fair | |||
Volatility Index | Fair | |||
Beta / Standard Deviation | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.02 | |||
Price History | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -3.52% | |||
30-Day Total Return | -13.96% | |||
60-Day Total Return | -13.80% | |||
90-Day Total Return | 4.09% | |||
Year to Date Total Return | -8.14% | |||
1-Year Total Return | 3.06% | |||
2-Year Total Return | 40.08% | |||
3-Year Total Return | 29.11% | |||
5-Year Total Return | 166.89% | |||
52-Week High % Change | -19.02% | |||
52-Week Low % Change | 13.02% | |||
Price | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $134.85 | |||
52-Week Low Price | $96.62 | |||
52-Week Low Price (Date) | Sep 11, 2024 | |||
52-Week High Price (Date) | Dec 04, 2024 | |||
Valuation | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 61.58B | |||
Enterprise Value | 72.89B | |||
Price/Earnings (TTM) | 26.00 | |||
Earnings Per Share (TTM) | 4.20 | |||
Earnings Per Share Growth | -78.15% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 3.55 | |||
Price/Book (Q) | 3.01 | |||
Enterprise Value/Revenue (TTM) | 4.15 | |||
Price | $111.76 | |||
Enterprise Value/EBITDA (TTM) | 14.56 | |||
Enterprise Value/EBIT | 21.13 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 571.10M | |||
Dividend Yield | 1.93% | |||
Div. Per Share (Most Recent) | $0.53 | |||
Dividend Per Share (TTM) | $2.11 | |||
Payout Ratio (TTM) | 49.85% | |||
Dividend Per Share (Most Recent) | $0.53 | |||
Company Info | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | (314) 553 2000 | |||
Address | 8000 West Florissant Avenue Saint Louis, MO 63136 | |||
Website | www.emerson.com | |||
Country | United States | |||
Year Founded | 1890 | |||
Profitability | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | 19.65% | |||
Profit Margin | 13.73% | |||
Management Effectiveness | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | 4.84% | |||
Return on Equity | 7.53% | |||
Income Statement | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 17.55B | |||
Total Revenue (TTM) | 17.55B | |||
Revenue Per Share | $30.73 | |||
Gross Profit (TTM) | 9.20B | |||
EBITDA (TTM) | 5.01B | |||
EBIT (TTM) | 3.45B | |||
Net Income (TTM) | 2.41B | |||
Net Income Avl. to Common (TTM) | 2.41B | |||
Total Revenue Growth (Q YOY) | 1.41% | |||
Earnings Growth (Q YOY) | 272.96% | |||
EPS Diluted (TTM) | 4.20 | |||
EPS Diluted Growth (Q YOY) | 319.93% | |||
Balance Sheet | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 2.83B | |||
Cash Per Share (Q) | $4.96 | |||
Total Current Assets (Q) | 9.19B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 26.38B | |||
Current Ratio (Q) | 1.543 | |||
Book Value Per Share (Q) | $36.34 | |||
Total Assets (Q) | 42.61B | |||
Total Current Liabilities (Q) | 5.96B | |||
Total Debt (Q) | 8.26B | |||
Total Liabilities (Q) | 16.23B | |||
Total Common Equity (Q) | 20.49B | |||
Cash Flow | EMR - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 2.95B | |||
Cash from Financing (TTM) | -5.80B | |||
Net Change in Cash (TTM) | 758.00M | |||
Levered Free Cash Flow (TTM) | 4.05B | |||
Cash from Operations (TTM) | 3.69B | |||